Product Wiki · Recalls · EU Safety Gate (RAPEX)

Joker 24K — recall SR/02217/25

EU Safety Gate (RAPEX) · Malta · 2025-06-20 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02217/25
Date of alert
2025-06-20
Country / jurisdiction
Malta
Risk level
Serious risk
Risk type
Chemical
Brand
JNR
Product category
Chemical products
Product type
Electronic cigarette
Barcode (EAN/GTIN)
6977704950099
Reported risk: The product can contain an excessive amount of liquid (declared value: 10 ml). This can lead to accidental consumption of a high dose of nicotine. Moreover, the product lacks a child-proof fastening and opening mechanism and is not protected from leaks. As a result, a child could become accidentally exposed to it when handling the product. Nicotine is acutely toxic and may endanger the safety of the user, especially if the product comes into contact with the skin or is ingested.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator to whom the measure were ordered
Other
Category of measure
Import rejected at border
Date of entry into force
02/06/2025
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10094709

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.